Thursday, October 22, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Banking & Insurance

Dividend-Heavy VanEck ETF Puts Its Money on Financials and Energy as Europe Dominates the Portfolio

SiterGedge by SiterGedge
June 8, 2026
in Banking & Insurance, Dividends, Energy & Oil, ETF, European Markets
0
VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF Stock
0
SHARES
52
VIEWS
Share on FacebookShare on Twitter

The VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF has built its €7.683 billion asset base on a simple premise: pay large, steady dividends and you earn a spot in the portfolio. That logic has produced a concentrated, almost contrarian, exposure that tilts heavily toward banks, oil majors, and pharmaceuticals — while technology barely registers. With the latest portfolio snapshot from June 4, the ETF’s structural bets are laid bare.

Sectors in Plain Sight

Financial services account for 31.72% of the fund’s equity weighting, the largest single sector holding. Energy comes next at 20.51%, followed by health care at 14.27% and defensive consumer goods at 9.77%. Technology, by contrast, weighs in at a mere 0.31% — a fraction of the share it commands in broad global equity benchmarks.

The concentration by sector is reinforced by a strict index methodology. The fund tracks the Morningstar Developed Markets Large Cap Dividend Leaders Screened Select Index, which limits any single sector to 40% and any individual stock to 5%. That cap is tested by Exxon Mobil, the top holding at 5.93% of assets — a slight overshoot that reflects a recent upward move in its share price. Verizon follows at 4.48%, with TotalEnergies, Nestlé, Shell, Pfizer, Roche, PepsiCo, Allianz and BP rounding out the top ten. Together, those ten names constitute 35.16% of the portfolio.

Europe Looms Large

Geographically, the ETF is far from a global mirror. Greater Europe commands 52.12% of the stock weighting, with the Eurozone alone contributing 27.22% and the United Kingdom 11.17%. The Americas account for 30.98% — split between the United States at 23.82% and Canada at 7.16%. This distribution reflects the index’s focus on developed markets only, deliberately excluding emerging economies.

The selection process favors companies with a strong dividend history and sustainable payouts, while also applying ESG screens. Weighting is based on total dividends paid, meaning the biggest cash distributors get the largest allocations. The fund uses full replication, buying all 100 index constituents directly. Its annual total expense ratio of 0.38% sits in the middle of the ETF fee range.

Should investors sell immediately? Or is it worth buying VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF?

Short-Term Slack, Long-Term Trend

At €51.90, the ETF edged up 0.48% from the prior Friday’s close, but the seven-day picture shows a dip of 0.65%. The price is hovering just below its 50-day moving average of €52.41, and remains roughly 4.7% below the April high of €54.48. The relative strength index of 43.1 suggests neither overbought nor oversold conditions — leaning neutral.

The longer view is more encouraging. The 200-day moving average of €48.86 sits well below the current price, implying a gain of about 6% from that level. Year-to-date, the fund has returned 7.32%, and over the past twelve months it has climbed 20.88% — a performance that underscores the resilience of its dividend-focused holdings through different market phases.

How It Stacks Up Against Peers

VanEck’s approach stands in contrast to broader alternatives such as Vanguard’s FTSE All-World High Dividend Yield UCITS ETF, which includes emerging markets and distributes its exposure more widely. BlackRock’s iShares MSCI World Quality Dividend Advanced UCITS ETF layers on quality filters and additional ESG criteria. The VanEck fund stays firmly in developed markets, making a clear bet on financials and energy as the primary engines of income.

That positioning means the ETF’s daily swings are tightly linked to the fortunes of banks, insurers, and integrated oil companies. For now, that equation is producing steady returns, even if the short-term momentum has softened slightly.

Ad

VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF Stock: Buy or Sell?! New VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF Analysis from October 22 delivers the answer:

The latest VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF figures speak for themselves: Urgent action needed for VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 22.

VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF: Buy or sell? Read more here...

Tags: VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF
SiterGedge

SiterGedge

Related Posts

Shell Stock
Commodities

Shell’s Gas Ambitions Meet Buyback Discipline as LNG Canada Talks Take Shape

September 25, 2026
Siemens Energy Stock
Energy & Oil

Siemens Energy: Nuclear Ambitions Meet Chart Warnings as CEO Urges Crisis Preparedness

September 7, 2026
Commerzbank Stock
Banking & Insurance

Commerzbank’s CEO Puts a Price on Her Future as UniCredit Circles Closer

September 7, 2026
Next Post
Bayer Stock

Bayer’s Technical Battle at the 200-Day Line Gets Reinforcement from Agriculture AI and Kidney Drug Progress

Nvidia Stock

Nvidia’s CEO Calls the Dip a ‘Discount’ as New PC Chip Takes Aim at Apple’s Turf

Palantir Stock

New Cloud and Construction Clients Can't Lift Palantir Past the 50-Day Line

Recommended

BioNTech Stock

BioNTech Investors Face Legal Challenge Following CureVac Acquisition

10 months ago
Eli Lilly Stock

Eli Lilly Faces Pricing Pressure as New Regulations Force Strategic Shift

1 year ago
MMM stock news

WestPark Capital Downgrades Palo Alto Networks to Hold Rating Despite Companys Resolute Stance

3 years ago
Inmune Bio Stock

Inmune Bio Navigates Strategic Shift Amid Market Pressures

1 year ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum DroneShield Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Most Stocks Rose While the Index Fell: Earnings Week Is the Test

Tesla Jumps on a Roadster as Tech Slips Into the Weekend

CoreWeave’s Bonds Flash Red as Strong Earnings Fall Flat

Hot Core CPI Sorts the Stocks: ASML Delivers, J&J Stumbles

Goldman Delivers as Memory Stocks Slide Ahead of CPI

Optics Run Hot as Chip Leaders Pause for Breath

Trending

Bitcoin Stock
Newsletter

Lam, Tesla and Meta Clear the Bar and Still Get Sold

by Stephanie Dugan
October 22, 2026
0

Dear readers, Wednesday's open question got its answer overnight. Lam Research told investors that global spending on...

Danaher Stock

Beat Estimates, Lose Ground: Guidance Now Drives Earnings Season

October 21, 2026
Mastercard Stock

The AI Rally Needs Cheap Money, and Cheap Money Is Scarce

October 20, 2026
Meta Stock

Most Stocks Rose While the Index Fell: Earnings Week Is the Test

October 18, 2026
Tesla Stock

Tesla Jumps on a Roadster as Tech Slips Into the Weekend

October 16, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Lam, Tesla and Meta Clear the Bar and Still Get Sold
  • Beat Estimates, Lose Ground: Guidance Now Drives Earnings Season
  • The AI Rally Needs Cheap Money, and Cheap Money Is Scarce

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com